title: Intra-lesional interferon injection for recurrent conjunctival MALT lymphoma.
authors.forename: M
authors.initials: M
authors.lastname: Zayed
authors.forename: K
authors.initials: K
authors.lastname: Sears
authors.forename: S M
authors.initials: SM
authors.lastname: Salvi
authors.forename: P A
authors.initials: PA
authors.lastname: Rundle
authors.forename: I G
authors.initials: IG
authors.lastname: Rennie
authors.forename: H S
authors.initials: HS
authors.lastname: Mudhar
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003230:Conjunctival Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000008:administration & dosage*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha
references.citation: Ophthalmology. 2012 Mar;119(3):494-500
references.pmid: 22226154
references.citation: Eur J Ophthalmol. 1996 Oct-Dec;6(4):475-7
references.pmid: 8997596
references.citation: Eye (Lond). 1987;1 ( Pt 1):90-6
references.pmid: 3556665
references.citation: Br J Ophthalmol. 2003 Sep;87(9):1191
references.pmid: 12928301
references.citation: Ophthalmology. 2001 Mar;108(3):559-62
references.pmid: 11237911